SEARCH

SEARCH BY CITATION

References

  • References to studies included in this review
  • Askie 2003 {published and unpublished data}
  • Askie LM, Henderson-Smart DJ, Irwig, L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. NEJM 2003;349(10):959-67.
  • Kinsey 1956 {published data only}
  • Kinsey VE. Cooperative study of retrolental fibroplasia and the use of oxygen. Archives of Ophthalmology 1956;56:481-543.
  • Lanman 1954 {published data only}
  • Lanman JT, Guy LP, Dancis J. Retrolental fibroplasia and oxygen therapy. JAMA 1954;155:223-6.
  • Patz 1954 {published data only}
  • * Patz A. Oxygen studies in retrolental fibroplasia. IV. Clinical and experimental observations. American Journal of Ophthalmology 1954;38:291-308.
  • Patz A. The role of oxygen in retrolental fibroplasia. Pediatrics 1957;19:504-24.
  • Patz A, Hoeck LE, Cruz E De La. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. American Journal of Ophthalmology 1952;36:1248-53.
  • Sinclair 1968 {published data only}
  • Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968;42:565-89.
  • Usher 1973 {published data only}
  • Coates AL, Desmond K, Willis D, Nogrady MB. Oxygen therapy and long-term pulmonary outcome of respiratory distress syndrome in newborns. Am J Dis Child 1982;136:892-895.
  • * Usher RH. Treatment of respiratory distress syndrome. In: WintersRW editor(s). The Body Fluids in Pediatrics. Boston & Toronto: Little, Brown and Company, 1974:303-337.
  • References to studies excluded from this review
  • Bard 1996 {published data only}
  • Bard H, Belanger S, Fouron J. Comparisons of effects of 95% and 90% oxygen saturations in respiratory distress syndrome. Archives of Disease in Childhood 1996;75:F94-6.
  • Cunningham 1995 {published data only}
  • Cunningham S, Fleck BW, Elton RA, McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 1995;346:1464-5.
  • Deulofeut 2007 {published data only}
  • Deulofeut R, Golde D, Augusto S. Treatment-by-gender effect when aiming to avoid hyperoxia in preterm infants in the NICU. Acta Paediatrica 2007;96(7):990-4.
  • Engleson 1958 {published data only}
  • * Engleson, G, Rooth G, Sjostedt S. Treatment of premature infants with 15% oxygen. Acta Paediatrica Scandinavica 1958;118 Suppl:47-9.
  • Rooth G, EnglesonG, Tornblom M. A follow-up study of premature infants treated with low oxygen tension. Acta Paediatrica Scandinavica 1966;55:85-7.
  • Sjostedt S, Rooth G. Low oxygen tension in the management of newborn infants. Archives of Disease in Childhood 1957;32:397-400.
  • Fitzgerald 1998 {published data only}
  • Fitzgerald D, Van Asperen PV, Leslie G, Arnold J, Sullivan C. Higher SaO2 in chronic neonatal lung disease: Does it improve sleep?. Pediatric Pulmonology 1998;26:235-40.
  • Gaynon 1997 {published data only}
  • Gaynon, MW, Stevenson DK, Sunshine P, Fleisher BE, Landers MB. Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity. Journal of Perinatology 1997;17:434-8.
  • Kitchen 1978 {published data only}
  • Kitchen WH, Campbell DG. Controlled trial of intensive care for very low birth weight infants. Pediatrics 1971;48:711-4.
  • Kitchen WH, Rickards A, Ryan MM, McDougall AB, Billson FA, Keir EH, Naylor FD. A longitudinal study of very low-birthweight infants. II. Results of controlled trial of intensive care and incidence of handicaps. Developmental Medicine and Child Neurology 1979;21:582-9.
  • * Kitchen WH, Ryan MM, Rickards A, Gaudry E, Brenton AM, Billson FA, Fortune DW, Keir EH, Lundahl-Hegedus EE. A longitudinal study of very low birthweight infants. I. Study design and mortality rates. Developmental Medicine and Child Neurology 1978;20:605-18.
  • Lundstrom 1995 {published data only}
  • Lundstrom KE, Larsen PB, Brendstrup L, Skov L, Greisen G. Cerebral blood flow and left ventricular output in spontaneously breathing, newborn preterm infants treated with caffeine or aminophylline. Acta Paediatrica 1995;84:6-9.
  • Lundstrom KE, Pryds O, Greisen G. 80% oxygen administration to newborn premature infants causes prolonged cerebral vasoconstriction [abstract]. Pediatric Research 1994;35:275.
  • * Lundstrom KE, Pryds O, Greisen G. Oxygen at birth and prolonged cerebral vasoconstriction in preterm infants. Archives of Disease in Childhood 1995;73:F81-F86.
  • Mendicini 1971 {published data only}
  • Mendicini M, Scalamandre A, Savignoni PG, Picece-Bucci S, Esuperanzi R, Bucci G. A controlled trial on therapy for newborns weighing 750-1250g. I. Clinical findings and mortality in the newborn period. Acta Paediatrica Scandinavica 1971;60:407-16.
  • Schulze 1995 {published data only}
  • Schulze A, Whyte RK, Way RC, Sinclair JC. Effect of the arterial oxygenation level on cardiac output, oxygen extraction, and oxygen consumption in low birth weight infants receiving mechanical ventilation. Journal of Pediatrics 1995;126:777-84.
  • STOP-ROP 2000 {published data only}
  • The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes. Pediatrics 2000;105:295-310.
  • Wallace 2007 {published data only}
  • Wallace DK, Veness-Meehan KA, Miller WC. Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels. J AAPOS 2007;11(2):170-4.
  • Weintraub 1956 {published data only}
  • Weintraub DH, Tabankin A. Relationship of retrolental fibroplasia to oxygen concentration. Journal of Pediatrics 1956;49:75-9.
  • Wright 2006 {published data only}
  • Wright KW, Sami D, Thompson L, Ramanathan R, Joseph R, Farzavandi S. A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Transactions of the American Ophthalmological Society 2006;104:78-84.
  • References to ongoing studies
  • BOOST NZ (NZ) {unpublished data only}
  • Benefits of oxygen saturation targeting trial (NZ). Ongoing study 2006.
  • BOOSTII (Australia) {unpublished data only}
  • Benefits of oxygen saturation targeting trial 2 (Australia). Ongoing study 2006.
  • BOOSTII (UK) {unpublished data only}
  • Benefits of oxygen saturation targeting trial 2 (UK). Ongoing study 2007.
  • COT (Canada) {unpublished data only}
  • Canadian oxygen trial. Ongoing study October 2006.
  • SUPPORT (USA) {unpublished data only}
  • The surfactant positive airway pressure and pulse oximetry trial in extremely low birth weight infants. Ongoing study February 2005.
  • Additional references
  • Anderson 2004
  • Anderson CG, Benitz WE, Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. Journal of Perinatology 2004;24(3):164-8.
  • Askie 2001a
  • Askie LM, Henderson-Smart DJ. Gradual versus abrupt discontinuation of oxygen in preterm or low birth weight infants. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001075]
  • Askie 2001b
  • Askie LM, Henderson-Smart DJ. Early versus late discontinuation of oxygen in preterm or low birth weight infants. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001076]
  • Avery 1960
  • Avery ME, Oppenheimer EH. Recent increase in mortality from hyaline membrane disease. Journal of Pediatrics 1960;57:553.
  • Bancalari 1987a
  • Bancalari E, Flynn J, Goldberg RN, Bawol R, Cassady J, Schiffman J, Feuer W, Roberts J, Gillings D, Sim E. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 1987;79:663-9.
  • Bancalari 1987b
  • Bancalari E, Flynn J, Goldberg RN, Bawol R, Cassady J, Schiffman J, Feuer W, Roberts J, Gillings D, Sim E. Transcutaneous oxygen monitoring and retinopathy of prematurity. Adv Exper Med Biol 1987;220:109-113.
  • Baraldi 2007
  • Baraldi E, Filippone M. Chronic lung disease after premature birth. New England Journal of Medicine 2007;357(19):1946-55.
  • Chan-Ling 1995
  • Chan-Ling T, Gock B, Stone J. Supplemental oxygen therapy. Basis for noninvasive treatment of retinopathy of prematurity. Investigative Ophthalmology and Visual Science 1995;36:1215-30.
  • Chow 2003
  • Chow LC, Wright KW, Sola S. Can changes in clinical practice decrease the incidence of severe retinopathy in very low birth weight infants?. Pediatrics 2003;111(2):339-45.
  • Coates 1982
  • Coates AL, Desmond K, Willis D, Nogrady B. Oxygen therapy and long-term pulmonary outcome of respiratory distress syndrome in newborns. American Journal of Diseases of Children 1982;136:892-5.
  • Cote 1988
  • Cote CJ, Goldstein EA, Cote MA, Hoaglin DC, Ryan JF. A single-blind study of pulse oximetry in children. Anesthesiology 1988;68:184-8.
  • Cross 1973
  • Cross KW. Cost of preventing retrolental fibroplasia?. Lancet 1973;2:954-6.
  • Duc 1992
  • Duc G, Sinclair JC. Oxygen Administration. In: SinclairJC, BrackenMB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992:178-98.
  • Flynn 1987
  • Flynn J, Bancalari E, Bawol R, Goldberg R, Cassady MA, Schiffman J, Feuer W, Roberts J, Gillings D, Sim E, Buckley E, Bachynski BN. Retinopathy of prematurity. A randomized prospective trial of transcutaneous oxygen monitoring. Ophthalmology 1987;94:630-637.
  • Garner 1985
  • Garner A. The pathology of retinopathy of prematurity. In: SilvermanWA, FlynnJT editor(s). Retinopathy of prematurity. Boston: Blackwell Scientific Publications, 1985:19-52.
  • Gunn 1980
  • Gunn TR, Easdown J, Outerbridge EW, Aranda JV. Risk factors in retrolental fibroplasia. Pediatrics 1980;65:1096-100.
  • Hindle 1986
  • Hindle NW. Cryotherapy for retinopathy of prematurity: timing of intervention. British Journal of Ophthalmology 1986;1986:269-76.
  • Hindle 1990
  • Hindle NW. Critical mass retinopathy of prematurity: What is it and what can you do about it?. Documenta Ophthalmologica 1990;74:253-62.
  • Jobe 2001
  • Jobe AH, Bancalari E. Bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine 2001;163:1723-9.
  • Kinsey 1977
  • Kinsey VE, Arnold HJ, Kalina RE, Stern L, Stahlman M, Odell G, Driscoll JM, Elliott JH, Payne J, Patz A. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 1977;60:655-68.
  • Lloyd 2003
  • Lloyd J, Askie L, Smith J, Tarnow-Mordi W. Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD003482]
  • McDonald 1963
  • McDonald AD. Cerebral palsy in children of low birth weight. Archives of Disease in Childhood 1963;38:579.
  • McIntosh 2001
  • McIntosh N, Marlow N. High or low oxygen saturation for the preterm baby. Archives of Disease in Childhood. Fetal and Neonatal Edition 2001;84:F149-50.
  • Payne 1979
  • Payne JW, Patz A. Current status of retrolental fibroplasia: the retinopathy of prematurity. Ann Clin Res 1979;11:205-21.
  • Phelps 1984
  • Phelps DL, Rosenbaum AL. Effects of marginal hypoxemia on recovery from oxygen-induced retinopathy in the kitten model. Pediatrics 1984;73:1-6.
  • Poets 1998
  • Poets CF. When do infants need additional inspired oxygen? A review of the current literature. Pediatric Pulmonology 1998;26:424-8.
  • Reese 1953
  • Reese AB, King M, Owens WC. A classification of retrolental fibroplasia. American Journal of Ophthalmology 1953;36:1333-5.
  • Roemer 2005
  • Roemer VM. Outcome measures in perinatal medicine--p02 and S02. With remarks on pulse oximetry. Zeitschrift fur Geburtshilfe und Neonatologie 2005;209:173-85.
  • ROP Committee 1984
  • Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. British Journal of Ophthalmology 1984;68:690-7.
  • ROP Committee 1987
  • Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. II The classification of retinal detachment. Archives of Ophthalmology 1987;105:906-12.
  • Sira 1988
  • Sira IB, Nissenkorn I, Kremer I. Retinopathy of prematurity. Survey of Ophthalmology 1988;33(1):1-16.
  • Sun 2002
  • Sun SC. Relation of target SpO2 levels and clinical outcome in ELBW infants on supplemental oxygen. Pediatric Research 2002;51:350A.
  • Szewcyk 1953
  • Szewcyk TS. Retrolental fibroplasia and related ocular diseases. American Journal of Ophthalmology 1953;36(10):1333-61.
  • Tin 2001
  • Tin W, Milligan DWA, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Archives of Disease in Childhood Fetal Neonatal Edition 2001;84:F106-10.
  • Watkin 1999
  • Watkin SL, Spencer SA, Dimmock PW, Wickramasinghe YA, Rolfe P. A comparison of pulse oximetry and near infrared spectroscopy (NIRS) in the detection of hypoxaemia occurring with pauses in nasal airflow in neonates. Journal of Clinical Monitoring and Computing 1999;15:441-7.
  • Wilson 1942
  • Wilson JL, Long SB, Howard PJ. Respiration of premature infants: response to variations of oxygen and to increased carbon dioxide in inspired air.. American Journal of Diseases of Children 1942:1080-5.
  • References to other published versions of this review
  • Askie 2001c
  • Askie LM, Henderson-Smart DJ. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants (Cochrane Review). Cochrane Database of Systematic Reviews 1999, Issue 2. [DOI: 10.1002/14651858.CD001077]